rs1057517429
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000487.6(ARSA):c.495_501delGCCGGCC(p.Pro166fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 1,457,726 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P165P) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000487.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSA | NM_000487.6 | c.495_501delGCCGGCC | p.Pro166fs | frameshift_variant | 3/8 | ENST00000216124.10 | NP_000478.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSA | ENST00000216124.10 | c.495_501delGCCGGCC | p.Pro166fs | frameshift_variant | 3/8 | 1 | NM_000487.6 | ENSP00000216124.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000823 AC: 2AN: 243028Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132708
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1457726Hom.: 0 AF XY: 0.0000179 AC XY: 13AN XY: 724688
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 28, 2022 | Variant summary: ARSA c.495_501delGCCGGCC (p.Pro166LeufsX32) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 8.2e-06 in 243028 control chromosomes (gnomAD). c.495_501delGCCGGCC has been reported in the literature in individuals affected with Metachromatic Leukodystrophy (e.g. Eng_2003, Coulter-Mackie_2003), including one case where it was confirmed to be in trans with a pathogenic variant. These data indicate that the variant is likely to be associated with disease. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 371638). This variant is also known as c.489_495del, p.Pro163fs or 752_758delGCCGGCC. This premature translational stop signal has been observed in individual(s) with metachromatic leukodystrophy (PMID: 12809638, 14517960). This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Pro166Leufs*32) in the ARSA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSA are known to be pathogenic (PMID: 8962139, 10477432). - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Nov 04, 2016 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 31, 2020 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 04, 2024 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Previously reported as c.489_495del & c.752_758del due to the use of alternate nomenclature; This variant is associated with the following publications: (PMID: 33951919, 12809638, 14517960) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at